Long acting β2-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection
- PMID: 28526052
- PMCID: PMC5437531
- DOI: 10.1186/s13019-017-0606-4
Long acting β2-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection
Abstract
Background: Long-acting β2-adrenoceptor agonists have been shown to increase the risk of atrial arrhythmias in patients with stable chronic obstructive pulmonary disease. The aim of this study was to investigate whether perioperative long-acting β2-adrenoceptor agonists treatment would increase the risk of postoperative atrial arrhythmias after lung cancer surgery in chronic obstructive pulmonary disease patients.
Methods: We retrospectively analyzed 174 consecutive chronic obstructive pulmonary disease patients with non-small-cell lung cancer who underwent lobectomy or segmentectomy. The subjects were divided into those with or without perioperative long-acting β2-adrenoceptor agonists treatment. Postoperative cardiopulmonary complications were compared between the two groups.
Results: There were no statistically significant differences between the perioperative long-acting β2-adrenoceptor agonists treatment group and the control group in the incidence of postoperative atrial arrhythmias (P = 0.629). In 134 propensity-score-matched pairs, including variables such as age, gender, comorbidities, smoking history, operation procedure, lung-cancer staging, and respiratory function, there were no significant differences between the two groups in the incidence of postoperative cardiopulmonary complications, including atrial arrhythmias.
Conclusions: Perioperative administration of long-acting β2-adrenoceptor agonists might not increase the incidence of postoperative atrial arrhythmias after surgical resection for non-small-cell lung cancer in chronic obstructive pulmonary disease patients.
Keywords: Long-acting β2-adrenoceptor agonists; Lung cancer surgery; Postoperative respiratory complications.
Figures


Similar articles
-
The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease.Gen Thorac Cardiovasc Surg. 2015 Dec;63(12):652-9. doi: 10.1007/s11748-015-0593-0. Epub 2015 Sep 29. Gen Thorac Cardiovasc Surg. 2015. PMID: 26419246
-
Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease.Gen Thorac Cardiovasc Surg. 2017 Jul;65(7):388-391. doi: 10.1007/s11748-017-0761-5. Epub 2017 Mar 9. Gen Thorac Cardiovasc Surg. 2017. PMID: 28281043 Free PMC article.
-
Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis.Eur J Cardiothorac Surg. 2014 Apr;45(4):640-5. doi: 10.1093/ejcts/ezt460. Epub 2013 Sep 19. Eur J Cardiothorac Surg. 2014. PMID: 24052605
-
A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.Drug Saf. 2004;27(10):689-715. doi: 10.2165/00002018-200427100-00001. Drug Saf. 2004. PMID: 15350154 Review.
-
[Recent advances in study of long β(2)-adrenoceptor agonist].Yao Xue Xue Bao. 2016 Dec;51(12):1838-44. Yao Xue Xue Bao. 2016. PMID: 29908535 Review. Chinese.
Cited by
-
Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.Drugs. 2018 Nov;78(16):1717-1740. doi: 10.1007/s40265-018-1001-8. Drugs. 2018. PMID: 30392114 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical